Effects of the WRITE Symptoms interventions on symptom and quality-of-life outcomes for women with recurrent ovarian cancer. GOG-259: An NRG Oncology/Gynecologic Oncology Group study

Life Outcomes ◽

Oncology Group ◽

Oncology Group Study ◽

Quality Of Life Outcomes

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study

Journal of Pain and Symptom Management ◽

10.1016/j.jpainsymman.2009.09.022 ◽

2010 ◽

Vol 39 (5) ◽

pp. 839-846 ◽

Cited By ~ 25

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Gibbons ◽

Bradley J. Monk ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Life Domains ◽

Oncology Group ◽

Clinical Factors ◽

The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.11.032 ◽

2012 ◽

Vol 124 (3) ◽

pp. 379-382 ◽

Cited By ~ 32

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Frasure ◽

Deborah K. Armstrong ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Overall Survival ◽

Adjuvant Chemotherapy ◽

Gynecologic Oncology ◽

Life Domains ◽

Oncology Group ◽

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70590-3 ◽

2006 ◽

Vol 2006 ◽

pp. 435-436

Author(s):

B.J. Monk

Keyword(s):

Quality Of Life ◽

Gynecologic Oncology ◽

Phase Iii ◽

Life Outcomes ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Advanced Carcinoma

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.05.017 ◽

2018 ◽

Vol 150 (1) ◽

pp. 119-126 ◽

Cited By ~ 3

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

David Cella ◽

MichaelA. Zevon ◽

Jason A. LaChance ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Care Needs ◽

Oncology Group Study ◽

Platinum Resistant

The association between quality of life and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5075 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5075-5075

Author(s):

V. E. Von Gruenigen ◽

H. Q. Huang ◽

K. M. Gil ◽

H. E. Frasure ◽

D. K. Armstrong ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Overall Survival ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Oncology Group ◽

Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group Study

European Journal of Cancer ◽

10.1016/s0959-8049(11)70122-8 ◽

2011 ◽

Vol 47 ◽

pp. 12 ◽

Cited By ~ 1

Author(s):

B.J. Monk ◽

H. Huang ◽

R.A. Burger ◽

R.L. Mannel ◽

H.D. Homesley ◽

...

Keyword(s):

Quality Of Life ◽

Controlled Trial ◽

Gynecologic Oncology ◽

Line Treatment ◽

Life Outcomes ◽

Oncology Group ◽

Front Line ◽

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70098-8 ◽

2006 ◽

Vol 2006 ◽

pp. 136-137

Author(s):

J.T. Thigpen

Keyword(s):

Quality Of Life ◽

Gynecologic Oncology ◽

Phase Iii ◽

Life Outcomes ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Advanced Carcinoma

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.047 ◽

2012 ◽

Vol 125 (2) ◽

pp. 315-319 ◽

Cited By ~ 22

Author(s):

Dana M. Chase ◽

Helen Q. Huang ◽

Lari Wenzel ◽

David Cella ◽

Richard McQuellon ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Cancer ◽

Gynecologic Oncology ◽

Advanced Cervical Cancer ◽

Oncology Group ◽

An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: A Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION

Annals of Oncology ◽

10.1093/annonc/mdz250.069 ◽

2019 ◽

Vol 30 ◽

pp. v432

Author(s):

J.-Y. Lee ◽

J.W. Kim ◽

B.G. Kim ◽

S. Kim ◽

H.S. Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Targeted Therapy ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Platinum Resistant

Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.07.121 ◽

2017 ◽

Vol 147 (1) ◽

pp. 98-103 ◽

Cited By ~ 10

Author(s):

N.T. Phippen ◽

A.A. Secord ◽

S. Wolf ◽

G. Samsa ◽

B. Davidson ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Data Analysis ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Advanced Epithelial Ovarian Cancer

Oncology Group ◽

Ancillary Data ◽